K. Wolk et al., Comparison of monocyte functions after LPS-or IL-10 induced reorientation:Importance in clinical immunoparalysis, PATHOBIOLOG, 67(5-6), 1999, pp. 253-256
Immunoparalysis is an acquired immunodeficiency which may occur in patients
after major surgery, burns, polytrauma and sepsis. It is associated with a
modified state of monocytes marked by their altered capacity to induce ant
igen-specific T cell stimulation and to release various cytokines. However,
the pathogenesis of immunoparalysis may differ in various patient groups.
It can develop in patients after systemic hyperinflammation induced by gast
rointestinal translocation of endotoxin (lipopolysaccharide, LPS) or sepsis
, as well as in patients without preceding systemic inflammation but primar
y anti-inflammation, for instance induced by sympathetic activation. To fur
ther elucidate the syndrome, we compared endotoxin tolerance as a model of
immunoparalysis after systemic hyperinflammation versus interleukin-10 (IL-
10) treatment as a model of primarily anti-inflammation-induced immunoparal
ysis. In vitro priming of peripheral blood mononuclear cells with either LP
S or IL-10 for 24 h led to a strongly or moderately diminished LPS-induced
tumor necrosis factor-alpha (TNF-alpha) production, compared to unprimed co
ntrols, respectively. Furthermore, LPS-induced reduction of TNF-alpha produ
ction capacity persisted over the following days whereas IL-10-primed monoc
ytes rapidly recovered. Similarly, in contrast to persistently diminished M
HC class II expression in LPS-treated monocytes, IL-10 only transiently dow
nregulated these molecules. Consequently, in contrast to IL-10-primed monoc
ytes, LPS-primed monocytes were greatly impaired in their capacity to induc
e antigen-specific T cell proliferation and IFN-gamma production. These dat
a indicate that LPS priming provokes a more profound modulation of monocyte
function than IL-10 priming, raising the question of possible variations i
n the clinical course of immunoparalysis, dependent on its pathogenesis. Co
pyright (C) 2000 S. Karger AG, Basel.